submit CrossRef Open Access Subscribe New Journal Ideal

Click on image to enlarge

International Journal of Translational ScienceJournal discontinued 2017


Pranela Rameshwar, Rutgers University, USA
Nicholas M. Ponzio, Rutgers University, USA

ISSN: 2246-8765 (Online Version)
Vol: 2016   Issue: 1

Published In:   January 2016

Publication Frequency: Continuous Article Publication

Search Available Volume and Issue for International Journal of Translational ScienceJournal discontinued 2017

Karl L. Mettinger, MD, PhD
Co-Founder, President and CEO, Cellastra Inc, San Francisco

Dr. Mettinger has more than 30 years of experience as an executive in the life science industry, and has been involved with the successful translational, early and late stage clinical development of new therapeutics, including a number of oncology, hematology, cardiovascular and CNS drugs and biologic products approved by the U.S. Food and Drug Administration, the European Medicines Agency, and other regulatory agencies worldwide. Dr. Mettinger served as Medical Director of Hematology and as Deputy General Manager of the cardiovascular business unit, of Kabi (Pharmacia, now part of Pfizer), in Sweden, as Medical Director/Executive Director at IVAX Corporation (now part of Teva Pharmaceutical Industries Ltd., NASDAQ:TEVA); Chief Medical Officer/Senior Vice President at SuperGen, (Astex, now part of Otsuka Pharmaceutical Ltd); Chief Medical Officer at Oncolytics Biotech Inc, AB (NASDAQ: ONCY; TSX: ONC); co-founder and past President of the Swedish Stroke Society, a 10,000-member stroke research and patient support organization. Dr. Mettinger received his M.D. from the University of Lund in Sweden and his Ph.D. in Hematology/Neurology from, and is a former Associate Professor of, the Karolinska Institutet/Karolinska University Hospital in Stockholm.

River Publishers: International Journal of Translational Science<sup><font color=#f91b02>Journal discontinued 2017</font></sup>